| Literature DB >> 31640548 |
Fatih Mehmet Ucar1, Cihan Ozturk2, Mustafa Adem Yılmaztepe2.
Abstract
BACKGROUND: Acute myocarditis (AM) can be defined as an inflammatory disease of the myocardium and characterized by large heterogeneity of clinical presentation. Myocarditis is becoming increasingly recognized as a contributor to unexplained mortality, and is thought to be a major cause of sudden cardiac death in the first two decades of life. The present study aimed to search the assessment of repolarization dispersion measured from the 12-lead surface electrocardiogram (including Tp-e interval, Tp-e/QT and Tp-e/QTc ratios) in AM patients.Entities:
Keywords: Acute myocarditis; Electrocardiography; Tp-e interval; Tp-e/QT ratio
Mesh:
Year: 2019 PMID: 31640548 PMCID: PMC6805629 DOI: 10.1186/s12872-019-1207-z
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Baseline demographic, clinical characteristics, and laboratory parameters of the study subjects
| Myocarditis Group ( | Control Group ( |
| |
|---|---|---|---|
| Male (%,n) | 67% (38) | 64% (36) | 0.69 |
| Age | 22 ± 3.7 | 23 ± 4.7 | 0.35 |
| Hyperlipidemia (%,n) | 10% [ | 3% [ | 0.14 |
| Smoking (%,n) | 14% [ | 5% [ | 0.11 |
| Body Mass index | 26.5 ± 3.4 | 26.5 ± 3.1 | 0.95 |
| Systolic Blood Pressure (mmhg) | 119 ± 12 | 123 ± 9 | 0.11 |
| Diastolic Blood Pressure (mmhg) | 75 ± 9 | 76 ± 8 | 0.57 |
| Glucose (mg/dL) | 99 ± 18.0 | 97 ± 17.5 | 0.58 |
| Creatinine (mg/dL) | 0.83 ± 0.12 | 0,80 ± 0.13 | 0.26 |
| Na (mEq/L) | 139 ± 2.5 | 140 ± 2.2 | 0.18 |
| K (mEq/L) | 4.4 ± 0.8 | 4.5 ± 0.3 | 0.78 |
| Ca (mg/dL) | 9.1 ± 0.4 | 9.0 ± 0.4 | 0.22 |
| AST (mg/dL) | 54 (9–159) | 20 (12–39) |
|
| ALT (mg/dL) | 28 (9–70) | 20 (6–52) |
|
| LDL (mg/dL) | 98 ± 30.9 | 108 ± 28.8 | 0.08 |
| HDL (mg/dL) | 37 ± 10.9 | 40 ± 9.1 | 0.09 |
| hs-CRP (mg/dL) | 4.16 ± 4.32 | 0,32 ± 0.15 |
|
| Wight blood cell, × 109/L | 9.7 ± 2.6 | 7.8 ± 1.9 |
|
| Neutrophil, × 109/L | 5.9 ± 0.50 | 6.6 ± 0.06 | 0,61 |
| Lymphocyte, × 109/L | 2.0 ± 0.25 | 1.5 ± 0.14 |
|
| Hemoglobin (mg/dL) | 14.5 ± 1.4 | 13.7 ± 1.3 | 0.74 |
Na Sodium, K Potassium, Ca Calcium, AST Aspartate aminotransferase, AST Alanine transaminase, LDL Low density lipoprotein, HDL High density lipoprotein, CRP C-reactive protein
AST-ALT-WBC-CRP AND Lymphocyte levels are boldface, because they are significant (p < 0.05)
Echocardiographic and electrocardiographic characteristics of the study population
| Myocarditis Group ( | Control Group ( |
| |
|---|---|---|---|
| Ejection Fraction (%) | 61 ± 7.7 | 63 ± 5.8 | 0.11 |
| LVEDD (mm) | 45 ± 4.8 | 46 ± 3.1 | 0.44 |
| LVESD (mm) | 30 ± 4.1 | 29 ± 3.9 | 0.36 |
| LVEDV (mL) | 191 ± 31,1 | 185 ± 31,7 | 187 ± 34,3 |
| LVESV (mL) | 127 ± 21,4 | 124 ± 24,1 | 125 ± 24,3 |
| Left atrial diameter (mm) | 31 ± 3.4 | 33 ± 3.9 | 0.13 |
| LAa (cm2) | 14.8 ± 3.3 | 15.0 ± 2.6 | 0.79 |
| LAv (cm3) | 39 ± 13.8 | 35 ± 8.8 | 0.08 |
| Heart rate (bpm) | 90 ± 19.3 | 75 ± 13.8 |
|
| QT interval (ms) | 370 ± 49.0 | 362 ± 30.2 | 0.33 |
| QTc interval (ms) | 437 ± 55.5 | 404 ± 32.5 |
|
| QRS interval (ms) | 118 ± 22.1 | 98 ± 10.0 |
|
| Tp-e interval (ms) | 85 ± 12.5 | 74 ± 7.3 |
|
| Tp-e/QT ratio | 0,23 ± 0.04 | 0,20 ± 0.02 |
|
| Tp-e/QTc ratio | 0,19 ± 0.03 | 0,18 ± 0.02 |
|
Data are represented as mean values ±SD. LVEDD Left Ventricle End Diastolic Diameter, LVESD Left Ventricle End Systolic Diameter, LVEDV Left ventricular end-diastolic volüme, LVESV Left ventricular end-systolic volüme, LAa Left atrial area, LAv Left atrial volume, mm millimeters, bpm beats per minute, Tp-e interval T-peak to T-end interval; c = rate corrected value; B = corrected with Bazett’s formula
AST-ALT-WBC-CRP AND Lymphocyte levels are boldface, because they are significant (p < 0.05)
Electrocardiographic characteristics of myocarditis patients with or without arrhythmia during hospitalization
| Arrhythmia Patients ( | No Arrhythmia Patients ( | p | |
|---|---|---|---|
| Heart rate (bpm) | 101 ± 36 | 89 ± 17 | 0.27 |
| QT interval (ms) | 355 ± 41.2 | 371 ± 49.7 | 0.52 |
| QTc interval (ms) | 453 ± 91.1 | 436 ± 53.1 | 0.55 |
| QRS interval (ms) | 100 ± 28.2 | 119 ± 21.2 | 0.08 |
| Tp-e interval (ms) | 95 ± 10.0 | 84 ± 12.4 | 0.11 |
| Tp-e/QT ratio | 0,27 ± 0.05 | 0,23 ± 0.04 | 0.07 |
| Tp-e/QTc ratio | 0,21 ± 0.04 | 0,19 ± 0.03 | 0.35 |
Data are represented as mean values ±SD. LVEDD: bpm beats per minute, Tp-e interval T-peak to T-end interval; c = rate corrected value; B = corrected with Bazett’s formula;
Fig. 1Correlation between troponin and peak and the end of the T wave (Tp-e) interval
Fig. 2Correlation between troponin and Tp-e/QT ratio, and Tp-e/corrected QT interval (QTc) ratio. a:Correlation between troponin values and Tp-e/QT ratio, b:Correlation between troponin values and Tp-e/corrected QT interval (QTc) ratio
Fig. 3Correlation between high-sensitivity CRP (hs-CRP) and peak and the end of the T wave (Tp-e) interval
Fig. 4Correlation between high-sensitivity CRP (hs-CRP) and Tp-e/QT ratio, and Tp-e/corrected QT interval (QTc) ratio. a:Correlation between high-sensitivity CRP (hs-CRP) and Tp-e/QT ratio, b:Correlation between high-sensitivity CRP (hs-CRP) and Tp-e/corrected QT interval (QTc) ratio